Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veerle Lejon

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
The American Journal of Tropical Medicine and Hygiene|August 5, 2011
Trypanosoma lewisi or T. lewisi-like infection in a 37-day-old Indian infantArchana Verma, Samiksha Manchanda, Nirmal Kumar, et al.
Plos Neglected Tropical Diseases|June 26, 2009
A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patientsAlexandre Hainard, Natalia Tiberti, Xavier Robin, et al.
Plos Neglected Tropical Diseases|June 13, 2014
Performance of parasitological and molecular techniques for the diagnosis and surveillance of gambiense sleeping sicknessDieudonné Mumba Ngoyi, Rosine Ali Ekangu, Marie France Mumvemba Kodi, et al.
Clinical and Translational Medicine|February 2, 2013
New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patientsNatalia Tiberti, Enock Matovu, Alexandre Hainard, et al.
Plos Neglected Tropical Diseases|March 8, 2013
Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sicknessNatalia Tiberti, Veerle Lejon, Alexandre Hainard, et al.
Plos Neglected Tropical Diseases|August 23, 2017
Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in GuineaJustin Windingoudi Kaboré, Hamidou Ilboudo, Harry Noyes, et al.
Bulletin of the World Health Organization|August 2, 2023
Target product profile: diagnostic test for <i>Trypanosoma brucei rhodesiense</i>Gerardo Priotto, Jose R Franco, Veerle Lejon, et al.
Bulletin of the World Health Organization|August 2, 2023
WHO target product profiles: four diagnostic tests needed in the effort to eliminate African trypanosomiasisGerardo Priotto, Jose R Franco, Veerle Lejon, et al.
Parasite (Paris, France)|December 23, 2022
Experimental evidence that immune trypanolysis using the LiTat 1.3 and LiTat 1.5 variant antigen types is not specific to Trypanosoma brucei gambiense in pigsKadidiata Ilboudo, Robert Eustache Hounyeme, Jacques Kabore, et al.
The Lancet. Infectious Diseases|December 28, 2019
New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practiceAndreas K Lindner, Veerle Lejon, François Chappuis, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
The American Journal of Tropical Medicine and Hygiene|August 5, 2011
Trypanosoma lewisi or T. lewisi-like infection in a 37-day-old Indian infantArchana Verma, Samiksha Manchanda, Nirmal Kumar, et al.
Plos Neglected Tropical Diseases|June 26, 2009
A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patientsAlexandre Hainard, Natalia Tiberti, Xavier Robin, et al.
Plos Neglected Tropical Diseases|June 13, 2014
Performance of parasitological and molecular techniques for the diagnosis and surveillance of gambiense sleeping sicknessDieudonné Mumba Ngoyi, Rosine Ali Ekangu, Marie France Mumvemba Kodi, et al.
Clinical and Translational Medicine|February 2, 2013
New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patientsNatalia Tiberti, Enock Matovu, Alexandre Hainard, et al.
Plos Neglected Tropical Diseases|March 8, 2013
Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sicknessNatalia Tiberti, Veerle Lejon, Alexandre Hainard, et al.
Plos Neglected Tropical Diseases|August 23, 2017
Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in GuineaJustin Windingoudi Kaboré, Hamidou Ilboudo, Harry Noyes, et al.
Bulletin of the World Health Organization|August 2, 2023
Target product profile: diagnostic test for <i>Trypanosoma brucei rhodesiense</i>Gerardo Priotto, Jose R Franco, Veerle Lejon, et al.
Bulletin of the World Health Organization|August 2, 2023
WHO target product profiles: four diagnostic tests needed in the effort to eliminate African trypanosomiasisGerardo Priotto, Jose R Franco, Veerle Lejon, et al.
Parasite (Paris, France)|December 23, 2022
Experimental evidence that immune trypanolysis using the LiTat 1.3 and LiTat 1.5 variant antigen types is not specific to Trypanosoma brucei gambiense in pigsKadidiata Ilboudo, Robert Eustache Hounyeme, Jacques Kabore, et al.
The Lancet. Infectious Diseases|December 28, 2019
New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practiceAndreas K Lindner, Veerle Lejon, François Chappuis, et al.
Pageof 10